1 day ago · Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium January 13, 2026 16:05 ET | Source: Foghorn Therapeutics, Inc.

Foghorn is pioneering a new class of medicines that treat serious disease by correcting abnormal gene expression. These precision therapeutic candidates target disease dependencies within …

A foghorn or fog signal is a device that uses sound to warn vehicles of navigational hazards such as rocky coastlines, or boats of the presence of other vessels, in foggy conditions.

1 day ago · WATERTOWN, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new …

3 days ago · Foghorn Therapeutics raised $50 million from leading biotech investors at a 30% premium, extending its cash runway into 2028. The company is advancing its lead SMARCA2 …

3 days ago · Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on …

5 days ago · Foghorn Therapeutics has successfully raised $50 million through equity financing with notable investors including BVF Partners and Deerfield Management, with the transaction …

1 day ago · Investors bought Foghorn shares and warrants for $50M at a 30% premium to market, with no underwriter involved and support from key biotech funds.

3 days ago · Investing.com - Stifel has reiterated a Buy rating and $12.00 price target on Foghorn Therapeutics (NASDAQ:FHTX) following the company’s announcement of an equity financing …

Timestamps: 0:18 - Introduction 1:01 - The Origins of the Foghorn 2:07 - How Sound Travels in Fog 2:48 - Early Steam-Powered Foghorns 3:12 - Modern Air and Electric Foghorns 4:25 - The...